Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pHIV-Luc-ZsGreen Citations (67)

Originally described in: pHIV Lentiviruses
Unpublished

Articles Citing pHIV-Luc-ZsGreen

Articles
Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine. DeRose YS, Gligorich KM, Wang G, Georgelas A, Bowman P, Courdy SJ, Welm AL, Welm BE. Curr Protoc Pharmacol. 2013 Mar;Chapter 14:Unit14.23. doi: 10.1002/0471141755.ph1423s60. PubMed
Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. Holmfeldt L, Mullighan CG. Curr Protoc Pharmacol. 2015 Mar 2;68:14.32.1-19. doi: 10.1002/0471141755.ph1432s68. PubMed
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nielsen SR, Quaranta V, Linford A, Emeagi P, Rainer C, Santos A, Ireland L, Sakai T, Sakai K, Kim YS, Engle D, Campbell F, Palmer D, Ko JH, Tuveson DA, Hirsch E, Mielgo A, Schmid MC. Nat Cell Biol. 2016 May;18(5):549-60. doi: 10.1038/ncb3340. Epub 2016 Apr 18. PubMed
Preventing Plasmon Coupling between Gold Nanorods Improves the Sensitivity of Photoacoustic Detection of Labeled Stem Cells in Vivo. Comenge J, Fragueiro O, Sharkey J, Taylor A, Held M, Burton NC, Park BK, Wilm B, Murray P, Brust M, Levy R. ACS Nano. 2016 Jul 26;10(7):7106-16. doi: 10.1021/acsnano.6b03246. Epub 2016 Jun 20. PubMed
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Dalin MG, Katabi N, Persson M, Lee KW, Makarov V, Desrichard A, Walsh LA, West L, Nadeem Z, Ramaswami D, Havel JJ, Kuo F, Chadalavada K, Nanjangud GJ, Ganly I, Riaz N, Ho AL, Antonescu CR, Ghossein R, Stenman G, Chan TA, Morris LGT. Nat Commun. 2017 Oct 30;8(1):1197. doi: 10.1038/s41467-017-01178-z. PubMed
Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation. Kojima R, Scheller L, Fussenegger M. Nat Chem Biol. 2018 Jan;14(1):42-49. doi: 10.1038/nchembio.2498. Epub 2017 Nov 13. PubMed
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Turcan S, Makarov V, Taranda J, Wang Y, Fabius AWM, Wu W, Zheng Y, El-Amine N, Haddock S, Nanjangud G, LeKaye HC, Brennan C, Cross J, Huse JT, Kelleher NL, Osten P, Thompson CB, Chan TA. Nat Genet. 2018 Jan;50(1):62-72. doi: 10.1038/s41588-017-0001-z. Epub 2017 Nov 27. PubMed
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells. Kolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S, Lightfoot H, Busacca S, Sharkey A, Yuan Z, Sage EK, Vallath S, Le Quesne J, Tice DA, Alrifai D, von Karstedt S, Montinaro A, Guppy N, Waller DA, Nakas A, Good R, Holmes A, Walczak H, Fennell DA, Garnett M, Iorio F, Wessels L, McDermott U, Janes SM. Elife. 2018 Jan 18;7. pii: 30224. doi: 10.7554/eLife.30224. PubMed
Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. Quaranta V, Rainer C, Nielsen SR, Raymant ML, Ahmed MS, Engle DD, Taylor A, Murray T, Campbell F, Palmer DH, Tuveson DA, Mielgo A, Schmid MC. Cancer Res. 2018 Aug 1;78(15):4253-4269. doi: 10.1158/0008-5472.CAN-17-3876. Epub 2018 May 22. PubMed
MELK Inhibition in Diffuse Intrinsic Pontine Glioma. Meel MH, de Gooijer MC, Guillen Navarro M, Waranecki P, Breur M, Buil LCM, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Montero Carcaboso A, Bugiani M, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E. Clin Cancer Res. 2018 Nov 15;24(22):5645-5657. doi: 10.1158/1078-0432.CCR-18-0924. Epub 2018 Jul 30. PubMed
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors. Urbani L, Camilli C, Phylactopoulos DE, Crowley C, Natarajan D, Scottoni F, Maghsoudlou P, McCann CJ, Pellegata AF, Urciuolo A, Deguchi K, Khalaf S, Aruta SF, Signorelli MC, Kiely D, Hannon E, Trevisan M, Wong RR, Baradez MO, Moulding D, Virasami A, Gjinovci A, Loukogeorgakis S, Mantero S, Thapar N, Sebire N, Eaton S, Lowdell M, Cossu G, Bonfanti P, De Coppi P. Nat Commun. 2018 Oct 16;9(1):4286. doi: 10.1038/s41467-018-06385-w. PubMed
Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteins. Bojar D, Fuhrer T, Fussenegger M. Metab Eng. 2019 Mar;52:110-123. doi: 10.1016/j.ymben.2018.11.007. Epub 2018 Nov 20. PubMed
Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration. Scarfe L, Taylor A, Sharkey J, Harwood R, Barrow M, Comenge J, Beeken L, Astley C, Santeramo I, Hutchinson C, Ressel L, Smythe J, Austin E, Levy R, Rosseinsky MJ, Adams DJ, Poptani H, Park BK, Murray P, Wilm B. Stem Cell Res Ther. 2018 Nov 28;9(1):332. doi: 10.1186/s13287-018-1076-x. PubMed
Multicolour In Vivo Bioluminescence Imaging Using a NanoLuc-Based BRET Reporter in Combination with Firefly Luciferase. Taylor A, Sharkey J, Plagge A, Wilm B, Murray P. Contrast Media Mol Imaging. 2018 Dec 3;2018:2514796. doi: 10.1155/2018/2514796. eCollection 2018. PubMed
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells. Fiskus W, Cai T, DiNardo CD, Kornblau SM, Borthakur G, Kadia TM, Pemmaraju N, Bose P, Masarova L, Rajapakshe K, Perera D, Coarfa C, Mill CP, Saenz DT, Saenz DN, Sun B, Khoury JD, Shen Y, Konopleva M, Bhalla KN. Blood Cancer J. 2019 Jan 15;9(2):4. doi: 10.1038/s41408-018-0165-5. PubMed
Non-Invasive Longitudinal Bioluminescence Imaging of Human Mesoangioblasts in Bioengineered Esophagi. Crowley C, Butler CR, Camilli C, Hynds RE, Kolluri KK, Janes SM, De Coppi P, Urbani L. Tissue Eng Part C Methods. 2019 Feb;25(2):103-113. doi: 10.1089/ten.TEC.2018.0351. PubMed
Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method. Liu Z, Wang Y, Kabraji S, Xie S, Pan P, Liu Z, Ni J, Zhao JJ. Sci Rep. 2019 Jan 24;9(1):622. doi: 10.1038/s41598-018-36874-3. PubMed
Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling. Lakshmanachetty S, Balaiya V, High WA, Koster MI. Mol Cancer Res. 2019 Jun;17(6):1279-1293. doi: 10.1158/1541-7786.MCR-18-1355. Epub 2019 Mar 25. PubMed
Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies. Rice MA, Hsu EC, Aslan M, Ghoochani A, Su A, Stoyanova T. Mol Cancer Ther. 2019 Jul;18(7):1230-1242. doi: 10.1158/1535-7163.MCT-18-0804. Epub 2019 Apr 26. PubMed
CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis. Dankner M, Ouellet V, Communal L, Schmitt E, Perkins D, Annis MG, Barres V, Caron C, Mes-Masson AM, Saad F, Siegel PM. Am J Pathol. 2019 Jul;189(7):1451-1461. doi: 10.1016/j.ajpath.2019.04.006. Epub 2019 Jun 12. PubMed
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors. Meel MH, Guillen Navarro M, de Gooijer MC, Metselaar DS, Waranecki P, Breur M, Lagerweij T, Wedekind LE, Koster J, van de Wetering MD, Schouten-van Meeteren N, Aronica E, van Tellingen O, Bugiani M, Phoenix TN, Kaspers GJL, Hulleman E. Neuro Oncol. 2020 Jan 11;22(1):58-69. doi: 10.1093/neuonc/noz151. PubMed
The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. Hashwah H, Bertram K, Stirm K, Stelling A, Wu CT, Kasser S, Manz MG, Theocharides AP, Tzankov A, Muller A. EMBO Mol Med. 2019 Oct;11(10):e10576. doi: 10.15252/emmm.201910576. Epub 2019 Sep 12. PubMed
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S, Blanco MA, Giera S, Gillespie SM, Das J, Wu M, Nocco S, Bonal DM, Nguyen QD, Suva ML, Bernstein BE, Alani R, Golub TR, Cole PA, Filbin MG, Shi Y. Cancer Cell. 2019 Nov 11;36(5):528-544.e10. doi: 10.1016/j.ccell.2019.09.005. Epub 2019 Oct 17. PubMed
Lung Mammary Metastases but Not Primary Tumors Induce Accumulation of Atypical Large Platelets and Their Chemokine Expression. Zheng W, Zhang H, Zhao D, Zhang J, Pollard JW. Cell Rep. 2019 Nov 12;29(7):1747-1755.e4. doi: 10.1016/j.celrep.2019.10.016. PubMed
Patient-Derived Scaffolds of Colorectal Cancer Metastases as an Organotypic 3D Model of the Liver Metastatic Microenvironment. D'Angelo E, Natarajan D, Sensi F, Ajayi O, Fassan M, Mammano E, Pilati P, Pavan P, Bresolin S, Preziosi M, Miquel R, Zen Y, Chokshi S, Menon K, Heaton N, Spolverato G, Piccoli M, Williams R, Urbani L, Agostini M. Cancers (Basel). 2020 Feb 5;12(2). pii: cancers12020364. doi: 10.3390/cancers12020364. PubMed
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Radhakrishnan SV, Luetkens T, Scherer SD, Davis P, Vander Mause ER, Olson ML, Yousef S, Panse J, Abdiche Y, Li KD, Miles RR, Matsui W, Welm AL, Atanackovic D. Nat Commun. 2020 Feb 7;11(1):798. doi: 10.1038/s41467-020-14619-z. PubMed
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Meel MH, de Gooijer MC, Metselaar DS, Sewing ACP, Zwaan K, Waranecki P, Breur M, Buil LCM, Lagerweij T, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Montero Carcaboso A, Bugiani M, Phoenix TN, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E. Clin Cancer Res. 2020 Jul 1;26(13):3319-3332. doi: 10.1158/1078-0432.CCR-19-3538. Epub 2020 Mar 12. PubMed
Recellularized Colorectal Cancer Patient-derived Scaffolds as in vitro Pre-clinical 3D Model for Drug Screening. Sensi F, D'Angelo E, Piccoli M, Pavan P, Mastrotto F, Caliceti P, Biccari A, Corallo D, Urbani L, Fassan M, Spolverato G, Riello P, Pucciarelli S, Agostini M. Cancers (Basel). 2020 Mar 13;12(3). pii: cancers12030681. doi: 10.3390/cancers12030681. PubMed
Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging Techniques. Mousavinejad M, Skidmore S, Barone FG, Tyers P, Pisupati V, Poptani H, Plagge A, Barker RA, Murray P, Taylor A, Hill CJ. Mol Imaging Biol. 2020 May 6. pii: 10.1007/s11307-020-01499-4. doi: 10.1007/s11307-020-01499-4. PubMed
CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages. Haabeth OAW, Hennig K, Fauskanger M, Loset GA, Bogen B, Tveita A. Blood Adv. 2020 Jun 23;4(12):2595-2605. doi: 10.1182/bloodadvances.2020001434. PubMed
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with (89)Zr-oxine PET-CT. Patrick PS, Kolluri KK, Zaw Thin M, Edwards A, Sage EK, Sanderson T, Weil BD, Dickson JC, Lythgoe MF, Lowdell M, Janes SM, Kalber TL. Stem Cell Res Ther. 2020 Jun 26;11(1):256. doi: 10.1186/s13287-020-01770-z. PubMed
Quantitative and multiplexed chemical-genetic phenotyping in mammalian cells with QMAP-Seq. Brockway S, Wang G, Jackson JM, Amici DR, Takagishi SR, Clutter MR, Bartom ET, Mendillo ML. Nat Commun. 2020 Nov 12;11(1):5722. doi: 10.1038/s41467-020-19553-8. PubMed
Plectin is a regulator of prostate cancer growth and metastasis. Buckup M, Rice MA, Hsu EC, Garcia-Marques F, Liu S, Aslan M, Bermudez A, Huang J, Pitteri SJ, Stoyanova T. Oncogene. 2021 Jan;40(3):663-676. doi: 10.1038/s41388-020-01557-9. Epub 2020 Nov 20. PubMed
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases. Dankner M, Caron M, Al-Saadi T, Yu W, Ouellet V, Ezzeddine R, Maritan SM, Annis MG, Le PU, Nadaf J, Neubarth NS, Savage P, Zuo D, Couturier CP, Monlong J, Djambazian H, Altoukhi H, Bourque G, Ragoussis J, Diaz RJ, Park M, Guiot MC, Lam S, Petrecca K, Siegel PM. Neuro Oncol. 2021 Sep 1;23(9):1470-1480. doi: 10.1093/neuonc/noab002. PubMed
A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs. Sassi L, Ajayi O, Campinoti S, Natarajan D, McQuitty C, Siena RR, Mantero S, De Coppi P, Pellegata AF, Chokshi S, Urbani L. Nanomaterials (Basel). 2021 Jan 21;11(2). pii: nano11020275. doi: 10.3390/nano11020275. PubMed
CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer. Tallon de Lara P, Castanon H, Vermeer M, Nunez N, Silina K, Sobottka B, Urdinez J, Cecconi V, Yagita H, Movahedian Attar F, Hiltbrunner S, Glarner I, Moch H, Tugues S, Becher B, van den Broek M. Nat Commun. 2021 Feb 3;12(1):769. doi: 10.1038/s41467-021-21045-2. PubMed
In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models. Attenello FJ, Tsung K, Bishara I, Loh YE, Chen TC. J Neurosci Res. 2021 Sep;99(9):2029-2045. doi: 10.1002/jnr.24850. Epub 2021 May 10. PubMed
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nielsen SR, Strobech JE, Horton ER, Jackstadt R, Laitala A, Bravo MC, Maltese G, Jensen ARD, Reuten R, Rafaeva M, Karim SA, Hwang CI, Arnes L, Tuveson DA, Sansom OJ, Morton JP, Erler JT. Nat Commun. 2021 Jun 7;12(1):3414. doi: 10.1038/s41467-021-23731-7. PubMed
Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies. Amadeo F, Plagge A, Chacko A, Wilm B, Hanson V, Liptrott N, Murray P, Taylor A. Eur J Nucl Med Mol Imaging. 2021 Jul 27. pii: 10.1007/s00259-021-05439-4. doi: 10.1007/s00259-021-05439-4. PubMed
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore. Wang B, Goh YS, Prince T, Ngoh EZX, Salleh SNM, Hor PX, Loh CY, Fong SW, Hartley C, Tan SY, Young BE, Leo YS, Lye DC, Maurer-Stroh S, Ng LFP, Hiscox JA, Renia L, Wang CI. NPJ Vaccines. 2021 Oct 25;6(1):125. doi: 10.1038/s41541-021-00389-2. PubMed
Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research. Cybula M, Wang L, Wang L, Drumond-Bock AL, Moxley KM, Benbrook DM, Gunderson-Jackson C, Ruiz-Echevarria MJ, Bhattacharya R, Mukherjee P, Bieniasz M. Cancers (Basel). 2021 Dec 15;13(24). pii: cancers13246288. doi: 10.3390/cancers13246288. PubMed
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection. Tay MZ, Rouers A, Fong SW, Goh YS, Chan YH, Chang ZW, Xu W, Tan CW, Chia WN, Torres-Ruesta A, Amrun SN, Huang Y, Hor PX, Loh CY, Yeo NK, Wang B, Ngoh EZX, Salleh SNM, Chavatte JM, Lim AJ, Maurer-Stroh S, Wang LF, Lin RVTP, Wang CI, Tan SY, Young BE, Leo YS, Lye DC, Renia L, Ng LF. EMBO Mol Med. 2022 Mar 7;14(3):e15227. doi: 10.15252/emmm.202115227. Epub 2022 Jan 21. PubMed
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model. Terada K, Kondo K, Ishigaki H, Nagashima A, Satooka H, Nagano S, Masuda K, Kawamura T, Hirata T, Ogasawara K, Itoh Y, Kawamoto H, Agata Y. Mol Ther Oncolytics. 2021 Dec 6;24:77-86. doi: 10.1016/j.omto.2021.12.003. eCollection 2022 Mar 17. PubMed
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M. J Exp Med. 2022 Feb 7;219(2). pii: 212965. doi: 10.1084/jem.20210815. Epub 2022 Jan 14. PubMed
Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model. Kamatani T, Otsuka R, Murata T, Wada H, Takahashi T, Mori A, Murata S, Taniguchi H, Seino KI. Inflamm Regen. 2022 Feb 2;42(1):4. doi: 10.1186/s41232-021-00190-7. PubMed
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics. Zhang L, Cheng C, Li J, Wang L, Chumanevich AA, Porter DC, Mindich A, Gorbunova S, Roninson IB, Chen M, McInnes C. J Med Chem. 2022 Feb 24;65(4):3420-3433. doi: 10.1021/acs.jmedchem.1c01951. Epub 2022 Feb 3. PubMed
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells. Haddock S, Alban TJ, Turcan S, Husic H, Rosiek E, Ma X, Wang Y, Bale T, Desrichard A, Makarov V, Monette S, Wu W, Gardner R, Manova K, Boire A, Chan TA. Neoplasia. 2022 Jun;28:100790. doi: 10.1016/j.neo.2022.100790. Epub 2022 Apr 7. PubMed
Secretory defects in pediatric osteosarcoma result from downregulation of selective COPII coatomer proteins. Wood RK, Flory AR, Mann MJ, Talbot LJ, Hendershot LM. iScience. 2022 Mar 17;25(4):104100. doi: 10.1016/j.isci.2022.104100. eCollection 2022 Apr 15. PubMed
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion. Olson ML, Mause ERV, Radhakrishnan SV, Brody JD, Rapoport AP, Welm AL, Atanackovic D, Luetkens T. Leukemia. 2022 Jul;36(7):1943-1946. doi: 10.1038/s41375-022-01585-2. Epub 2022 Apr 30. PubMed
Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants. Lim SM, Cheng HL, Jia H, Kongsuphol P, D/O Shunmuganathan B, Chen MW, Ng SY, Gao X, Turaga SP, Heussler SP, Somani J, Sengupta S, Tay DMY, McBee ME, Young BE, MacAry PA, Sikes HD, Preiser PR. Bioeng Transl Med. 2022 Feb 10;7(2):e10293. doi: 10.1002/btm2.10293. eCollection 2022 May. PubMed
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies. Kongsuphol P, Jia H, Cheng HL, Gu Y, Shunmuganathan BD, Chen MW, Lim SM, Ng SY, Tambyah PA, Nasir H, Gao X, Tay D, Kim S, Gupta R, Qian X, Kozma MM, Purushotorman K, McBee ME, MacAry PA, Sikes HD, Preiser PR. Commun Med (Lond). 2021 Nov 11;1:46. doi: 10.1038/s43856-021-00045-9. eCollection 2021. PubMed
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer. Brown MS, Abdollahi B, Wilkins OM, Lu H, Chakraborty P, Ognjenovic NB, Muller KE, Jolly MK, Christensen BC, Hassanpour S, Pattabiraman DR. Sci Adv. 2022 Aug 5;8(31):eabj8002. doi: 10.1126/sciadv.abj8002. Epub 2022 Aug 3. PubMed
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment. Papadas A, Deb G, Cicala A, Officer A, Hope C, Pagenkopf A, Flietner E, Morrow ZT, Emmerich P, Wiesner J, Arauz G, Bansal V, Esbona K, Capitini CM, Matkowskyj KA, Deming DA, Politi K, Abrams SI, Harismendy O, Asimakopoulos F. Cell Rep. 2022 Aug 16;40(7):111201. doi: 10.1016/j.celrep.2022.111201. PubMed
DEAE-Dextran Enhances the Lentiviral Transduction of Primary Human Mesenchymal Stromal Cells from All Major Tissue Sources Without Affecting Their Proliferation and Phenotype. Amadeo F, Hanson V, Murray P, Taylor A. Mol Biotechnol. 2023 Apr;65(4):544-555. doi: 10.1007/s12033-022-00549-2. Epub 2022 Aug 23. PubMed
Therapeutic Nanocarriers Inhibit Chemotherapy-Induced Breast Cancer Metastasis. Li T, Akinade T, Zhou J, Wang H, Tong Q, He S, Rinebold E, Valencia Salazar LE, Bhansali D, Zhong Y, Ruan J, Du J, Dalerba P, Leong KW. Adv Sci (Weinh). 2022 Nov;9(33):e2203949. doi: 10.1002/advs.202203949. Epub 2022 Oct 11. PubMed
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Adua SJ, Arnal-Estape A, Zhao M, Qi B, Liu ZZ, Kravitz C, Hulme H, Strittmatter N, Lopez-Giraldez F, Chande S, Albert AE, Melnick MA, Hu B, Politi K, Chiang V, Colclough N, Goodwin RJA, Cross D, Smith P, Nguyen DX. Nat Commun. 2022 Dec 12;13(1):7690. doi: 10.1038/s41467-022-34889-z. PubMed
Fate of intravenously administered umbilical cord mesenchymal stromal cells and interactions with the host's immune system. Amadeo F, Hanson V, Liptrott NJ, Wilm B, Murray P, Taylor A. Biomed Pharmacother. 2023 Mar;159:114191. doi: 10.1016/j.biopha.2022.114191. Epub 2023 Jan 7. PubMed
Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities. Schott CR, Koehne AL, Sayles LC, Young EP, Luck C, Yu K, Lee AG, Breese MR, Leung SG, Xu H, Shah AT, Liu HY, Spillinger A, Behroozfard IH, Marini KD, Dinh PT, Pons Ventura MAV, Vanderboon EN, Hazard FK, Cho SJ, Avedian RS, Mohler DG, Zimel M, Wustrack R, Curtis C, Sirota M, Sweet-Cordero EA. bioRxiv. 2023 Jan 20:2023.01.19.524562. doi: 10.1101/2023.01.19.524562. Preprint. PubMed
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. Nilsson MB, Yang Y, Heeke S, Patel SA, Poteete A, Udagawa H, Elamin YY, Moran CA, Kashima Y, Arumugam T, Yu X, Ren X, Diao L, Shen L, Wang Q, Zhang M, Robichaux JP, Shi C, Pfeil AN, Tran H, Gibbons DL, Bock J, Wang J, Minna JD, Kobayashi SS, Le X, Heymach JV. Cancer Cell. 2023 Feb 13;41(2):340-355.e6. doi: 10.1016/j.ccell.2023.01.007. PubMed
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis. Zou H, Poore B, Brown EE, Qian J, Xie B, Asimakidou E, Razskazovskiy V, Ayrapetian D, Sharma V, Xia S, Liu F, Chen A, Guan Y, Li Z, Wanggou S, Saulnier O, Ly M, Fellows-Mayle W, Xi G, Tomita T, Resnick AC, Mack SC, Raabe EH, Eberhart CG, Sun D, Stronach BE, Agnihotri S, Kohanbash G, Lu S, Herrup K, Rich JN, Gittes GK, Broniscer A, Hu Z, Li X, Pollack IF, Friedlander RM, Hainer SJ, Taylor MD, Hu B. Nat Cell Biol. 2023 Mar;25(3):493-507. doi: 10.1038/s41556-023-01093-0. Epub 2023 Feb 27. PubMed
Long noncoding RNA Malat1 inhibits Tead3-Nfatc1-mediated osteoclastogenesis to suppress osteoporosis and bone metastasis. Zhao Y, Teng H, Deng Y, Sheldon M, Martinez C, Zhang J, Tian A, Sun Y, Nakagawa S, Yao F, Wang H, Ma L. Res Sq. 2023 Mar 20:rs.3.rs-2405644. doi: 10.21203/rs.3.rs-2405644/v1. Preprint. PubMed
Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. Bagheri M, Mohamed GA, Ashick M, Saleem M, Ognjenovic NB, Lu H, Kolling FW, Wilkins OM, Das S, Croix IS, Nagaraj SH, Muller KE, Gerber SA, Miller TW, Pattabiraman DR. bioRxiv. 2023 Apr 21:2023.04.19.537586. doi: 10.1101/2023.04.19.537586. Preprint. PubMed
CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins. Chen M, Li J, Zhang L, Wang L, Cheng C, Ji H, Altilia S, Ding X, Cai G, Altomare D, Shtutman M, Byrum SD, Mackintosh SG, Feoktistov A, Soshnikova N, Mogila VA, Tatarskiy V, Erokhin M, Chetverina D, Prawira A, Ni Y, Urban S, McInnes C, Broude EV, Roninson IB. Nucleic Acids Res. 2023 Aug 11;51(14):7288-7313. doi: 10.1093/nar/gkad538. PubMed
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression. Rafaeva M, Jensen ARD, Horton ER, Zornhagen KW, Strobech JE, Fleischhauer L, Mayorca-Guiliani AE, Nielsen SR, Gronseth DS, Kus F, Schoof EM, Arnes L, Koch M, Clausen-Schaumann H, Izzi V, Reuten R, Erler JT. Front Immunol. 2023 Jul 18;14:1154528. doi: 10.3389/fimmu.2023.1154528. eCollection 2023. PubMed
Alternative splicing of its 5' UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies. Ang Z, Paruzzo L, Hayer KE, Schmidt C, Torres-Diz M, Xu F, Zankharia U, Zhang Y, Soldan SS, Zheng S, Falkenstein CD, Loftus JP, Yang SY, Asnani M, King Sainos P, Pillai V, Chong ER, Li M, Tasian SK, Barash Y, Lieberman PM, Ruella M, Schuster SJ, Thomas-Tikhonenko A. Blood. 2023 Sep 8:blood.2023020400. doi: 10.1182/blood.2023020400. PubMed

Associated Plasmids
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. Ye J, Liu W, Yu X, Wu L, Chen Z, Yu Y, Wang J, Bai S, Zhang M. Cell Death Discov. 2023 Oct 16;9(1):378. doi: 10.1038/s41420-023-01675-9. PubMed
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2. Gu Y, Shunmuganathan B, Qian X, Gupta R, Tan RSW, Kozma M, Purushotorman K, Murali TM, Tan NYJ, Preiser PR, Lescar J, Nasir H, Somani J, Tambyah PA, Smith KGC, Renia L, Ng LFP, Lye DC, Young BE, MacAry PA. Sci Rep. 2023 Dec 9;13(1):21810. doi: 10.1038/s41598-023-49231-w. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.